Tiny molecule controls stress-induced heart disease

A tiny snippet of RNA, a chemical cousin of DNA, controls damage to the heart under several types of stress, researchers at UT Southwestern Medical Center have found.

The published discovery, appearing online today on Science Express and in a later edition of Science magazine, could mean that blocking the small molecule might become a way to prevent or treat heart damage, the scientists say.

"We've discovered a new and completely unanticipated mechanism for regulating the contractility of the heart," said Dr. Eric Olson, chairman of molecular biology and senior author of the study. "We're very excited about the therapeutic implications, but we still have much work left to do."

Dr. Olson is director of the Nancy B. and Jake L. Hamon Center for Basic Research in Cancer and the Nearburg Family Center for Basic Research in Pediatric Oncology.

When adult heart cells contract, they use two forms of a protein called myosin. One form, called alpha-myosin heavy chain, is fast and efficient, while beta-myosin heavy chain is slower and less efficient. When the heart is damaged, the amount of alpha-myosin decreases and the proportion of beta-myosin increases.

The research focused on a small RNA molecule – called a microRNA – named miR-208, which occurs almost exclusively in heart muscle. The molecule is made by a portion of the gene that codes for the alpha-myosin protein.

"We speculated that it had an important function, since it was located in such an important gene," said Dr. Eva van Rooij, a postdoctoral researcher in molecular biology and the study's lead author.

The scientists genetically engineered a group of mice so they couldn't produce miR-208. The mice were then subjected to conditions that would normally damage the heart and increase the amount of beta-myosin. Those conditions included hypothyroidism, treatment with a protein that causes heart enlargement and failure, and increasing how hard the heart had to pump.

In mice that had miR-208 present at normal levels, heart damage occurred. But in the animals lacking miR-208, the heart remained healthier, at least in the short term, and levels of beta-myosin remained low.

The researchers also engineered mice to express three times the normal level of miR-208, and found that they had elevated levels of beta-myosin. Work is currently under way to see if those mice show heart damage.

MiR-208 is identical in humans, mice and other animals, indicating that it has a basic and widespread function in controlling heart damage, Dr. Olson said.

The work suggests that if miR-208 can be tied up or eliminated by therapeutic treatment, it might be a way to treat heart disease, Dr. van Rooij said. "That would be golden, because even a tiny increase in beta-myosin heavy chain in humans has been proven to diminish heart function," she said.

Although miR-208 appears to damage the heart during stress, it may have beneficial functions for maintaining normal action of heart muscle cells, Dr. Olson said. So any therapeutic approach would probably need to target its harmful stress responses while leaving normal function alone, he said.

Source: UT Southwestern Medical Center

Related stories:

Researchers devise means to create blood by identifying earliest stem cells
Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow. They also found a surprising biological marker that pinpoints these stem cells, which serve as the progenitors for red blood cells and lymphocytes.
Normalizing tumor vessels to improve cancer therapy
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal—"leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston.
Alcohol consumption can cause too much cell death, fetal abnormalities
The initial signs of fetal alcohol syndrome are slight but classic: facial malformations such as a flat and high upper lip, small eye openings and a short nose.
Joslin study identifies protein that produces 'good' fat
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.
That tastes -- sweet? Sour? No, it's definitely calcium!
Chemists in Philadelphia are reporting a discovery that could expand the palate of human tastes — sweet, sour, salty, bitter, and savory — to include a new taste sensation that they term "calcium."
Limbs saved by menstrual blood stem cells
Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. A study published today in BioMed Central's open access Journal of Translational Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality were restored.
Light receptors in eye play key role in setting biological clock
Biologists at the University of Virginia have discovered a switching mechanism in the eye that plays a key role in regulating the sleep/wake cycles in mammals.
Trapping white blood cells proves novel strategy against chronic viral infections
Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found.

News discussion:

Medicine & Health news